NSAIDs: Learning new tricks from old drugs

European Journal of Immunology

Volumn 45, Issue 3, 2015, Pages 679-686

  Díaz González, Federico ^a   Sánchez Madrid, Francisco ^b  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

L selectin; NADPH oxidase; Non steroidal anti inflammatory drugs

Indexed keywords

L SELECTIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANION TRANSPORT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CELL AGGREGATION; CELL MEMBRANE; CONFORMATIONAL TRANSITION; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; ENZYME INHIBITION; EXTRAVASATION; HUMAN; INFLAMMATION; MOLECULAR INTERACTION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN POLYMERIZATION; RESPIRATORY BURST; STRUCTURE ACTIVITY RELATION; ANIMAL; ANTAGONISTS AND INHIBITORS; FEVER; IMMUNOLOGY; PAIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL MEMBRANE; FEVER; HUMANS; INFLAMMATION; L-SELECTIN; NADPH OXIDASE; NEUTROPHILS; PAIN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SUPEROXIDES;

EID: 84924580262     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445222     Document Type: Article

References (73)

1. Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A. and Vane, J. R., Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl. Acad. Sci. USA 1999. 96: 7563-7568.
2. Gan, T. J., Diclofenac: an update on its mechanism of action and safety profile. Curr. Med. Res. Opin. 2010. 26: 1715-1731.
3. Pereira-Leite, C., Nunes, C. and Reis, S., Interaction of nonsteroidal anti-inflammatory drugs with membranes: in vitro assessment and relevance for their biological actions. Prog. Lipid Res. 2013. 52: 571-584.
4. Khajeh, A. and Modarress, H., The influence of cholesterol on interactions and dynamics of ibuprofen in a lipid bilayer. Biochim. Biophys. Acta 2014. 1838: 2431-2438.
5. Diaz-Gonzalez, F., Gonzalez-Alvaro, I., Campanero, M. R., Mollinedo, F., del Pozo, M. A., Munoz, C., Pivel, J. P. et al., Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs. J.Clin. Invest. 1995. 95: 1756-1765.
6. Liggett, J. L., Min, K. W., Smolensky, D. and Baek, S. J., A novel COX-independent mechanism of sulindac sulfide involves cleavage of epithelial cell adhesion molecule protein. Exp. Cell Res. 2014. 326: 1-9.
7. Dominguez-Jimenez, C., Diaz-Gonzalez, F., Gonzalez-Alvaro, I., Cesar, J. M. and Sanchez-Madrid, F., Prevention of alphaII(b)beta3 activation by non-steroidal antiinflammatory drugs. FEBS Lett. 1999. 446: 318-322.
8. Zarbock, A. and Rossaint, J., L-selectin shedding by NSAIDs: old friends in new dresses. Eur. J. Immunol. 2013. 43: 50-54.
9. Garcia-Vicuna, R., Diaz-Gonzalez, F., Gonzalez-Alvaro, I., del Pozo, M. A., Mollinedo, F., Cabanas, C., Gonzalez-Amaro, R. et al., Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family. Arthritis Rheum. 1997. 40: 143-153.
10. Gomez-Gaviro, M. V., Gonzalez-Alvaro, I., Dominguez-Jimenez, C., Peschon, J., Black, R. A., Sanchez-Madrid, F. and Diaz-Gonzalez, F., Structure-function relationship and role of tumor necrosis factor-alpha-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs. J. Biol. Chem. 2002. 277: 38212-38221.
11. Herrera-Garcia, A., Dominguez-Luis, M., Arce-Franco, M., Lopez-Fernandez, J., Feria, M., Barreiro, O., Sanchez-Madrid, F. et al., In vivo modulation of the inflammatory response by nonsteroidal antiinflammatory drug-related compounds that trigger L-selectin shedding. Eur. J. Immunol. 2013. 43: 55-64.
12. Dominguez-Luis, M., Herrera-Garcia, A., Arce-Franco, M., Armas-Gonzalez, E., Rodriguez-Pardo, M., Lorenzo-Diaz, F., Feria, M. et al., Superoxide anion mediates the L-selectin down-regulation induced by non-steroidal anti-inflammatory drugs in human neutrophils. Biochem. Pharmacol. 2013. 85: 245-256.
13. Dovizio, M., Tacconelli, S., Sostres, C., Ricciotti, E. and Patrignani, P., Mechanistic and pharmacological issues of aspirin as an anticancer agent. Pharmaceuticals 2012. 5: 1346-1371.
14. Ajmone-Cat, M. A., Bernardo, A., Greco, A. and Minghetti, L., Non-steroidal anti-inflammatory drugs and brain inflammation: Effects on microglial functions. Pharmaceuticals 2010. 3: 1949-1964.
15. Weggen, S., Rogers, M. and Eriksen, J., NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development? Trends Pharmacol. Sci. 2007. 28: 536-543.
16. Vane, J. R., Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 1971. 231: 232-235.
17. Simmons, D. L., Botting, R. M. and Hla, T., Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 2004. 56: 387-437.
18. Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., Van De Putte, L. B. and Lipsky, P. E., Cyclooxygenase in biology and disease. FASEB J. 1998. 12: 1063-1073.
19. Smith, W. L., Urade, Y. and Jakobsson, P. J., Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem. Rev. 2011. 111: 5821-5865.
20. Ballou, L. R. and Wang, B. W. E., Nonsteroidal Anti-inflammatory Drugs. In Firestein, G. S., Budd, R. C., Harris, E. D., MacInnes, I. B., Ruddy, S. and Sergent, J. S. (Eds.), Kelleýs textbook of rheumatology, 8th Edn. Saunders Elsevier, Philadelphia 2009, pp. 833-862.
21. Fantone, J. C., Marasco, W. A., Elgas, L. J. and Ward, P. A., Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil. J. Immunol. 1983. 130: 1495-1497.
22. Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J. and Vane, J. R., Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA 1993. 90: 11693-11697.
23. Bombardier, C., Peloso, P. M. and Goldsmith, C. H., Salsalate, a nonacetylated salicylate, is as efficacious as diclofenac in patients with rheumatoid arthritis. Salsalate-Diclofenac Study Group. J. Rheumatol. 1995. 22: 617-624.
24. Abramson, S. B. and Weissmann, G., The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1989. 32: 1-9.
25. Dinchuk, J. E., Car, B. D., Focht, R. J., Johnston, J. J., Jaffee, B. D., Covington, M. B., Contel, N. R. et al., Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995. 378: 406-409.
26. Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F. et al., Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995. 83: 473-482.
27. Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F. et al., Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995. 83: 483-492.
28. Walker, J. S., Sheather-Reid, R. B., Carmody, J. J., Vial, J. H. and Day, R. O., Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders". Arthritis Rheum. 1997. 40: 1944-1954.
29. Lichtenberger, L. M., Zhou, Y., Jayaraman, V., Doyen, J. R., O'Neil, R. G., Dial, E. J., Volk, D. E. et al., Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine. Biochim. Biophys. Acta 2012. 1821: 994-1002.
30. Altman, R. D., Neutrophil activation: an alternative to prostaglandin inhibition as the mechanism of action for NSAIDs. Semin. Arthritis Rheum. 1990. 19: 1-5.
31. Bertolotto, M., Contini, P., Ottonello, L., Pende, A., Dallegri, F. and Montecucco, F., Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathways. Br. J. Pharmacol. 2014. 171: 3376-3393.
32. Tanaka, J., Yuda, Y. and Yamakawa, T., Mechanism of superoxide generation system in indomethacin-induced gastric mucosal injury in rats. Biol. Pharm. Bull. 2001. 24: 155-158.
33. Pillinger, M. H., Capodici, C., Rosenthal, P., Kheterpal, N., Hanft, S., Philips, M. R. and Weissmann, G., Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion. Proc. Natl. Acad. Sci. USA 1998. 95: 14540-14545.
34. Barnes, P. J. and Karin, M., Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997. 336: 1066-1071.
35. Yin, M. J., Yamamoto, Y. and Gaynor, R. B., The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998. 396: 77-80.
36. Sakurada, S., Kato, T. and Okamoto, T., Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin. Int. Immunol. 1996. 8: 1483-1493.
37. Yoo, C. G., Lee, S., Lee, C. T., Kim, Y. W., Han, S. K. and Shim, Y. S., Effect of acetylsalicylic acid on endogenous I kappa B kinase activity in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001. 280: L3-9.
38. Weber, C., Erl, W., Pietsch, A. and Weber, P. C., Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 1995. 91: 1914-1917.
39. Scheuren, N., Bang, H., Munster, T., Brune, K. and Pahl, A., Modulation of transcription factor NF-kappaB by enantiomers of the nonsteroidal drug ibuprofen. Br. J. Pharmacol. 1998. 123: 645-652.
40. Kazmi, S. M., Plante, R. K., Visconti, V., Taylor, G. R., Zhou, L. and Lau, C. Y., Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. J Cell. Biochem. 1995. 57: 299-310.
41. Ou, Y. C., Yang, C. R., Cheng, C. L., Raung, S. L., Hung, Y. Y. and Chen, C. J., Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Eur. J. Pharmacol. 2007. 563: 49-60.
42. Vaish, V., Tanwar, L. and Sanyal, S. N., The role of NF-kappaB and PPARgamma in experimentally induced colorectal cancer and chemoprevention by cyclooxygenase-2 inhibitors. Tumour Biol. 2010. 31: 427-436.
43. Kashfi, K. and Rigas, B., Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention. Biochem. Pharmacol. 2005. 70: 969-986.
44. Barreiro, O., Martin, P., Gonzalez-Amaro, R. and Sanchez-Madrid, F., Molecular cues guiding inflammatory responses. Cardiovasc. Res. 2010. 86: 174-182.
45. Ley, K., Laudanna, C., Cybulsky, M. I. and Nourshargh, S., Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007. 7: 678-689.
46. Ghosh, S. and Panaccione, R., Anti-adhesion molecule therapy for inflammatory bowel disease. Therap. Adv. Gastroenterol. 2010. 3: 239-258.
47. Griffith, J. W. and Luster, A. D., Targeting cells in motion: migrating toward improved therapies. Eur. J. Immunol. 2013. 43: 1430-1435.
48. Sunasee, R., Adokoh, C. K., Darkwa, J. and Narain, R., Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems. Expert Opin. Drug Deliv. 2014. 11: 867-884.
49. Basmenji, S., Valizadeh, H. and Zakeri-Milani, P., Comparative in vitro dissolution and in vivo bioequivalence of two diclofenac enteric coated formulations. Arzneimittelforschung 2011. 61: 566-570.
50. Kokki, H., Kumpulainen, E., Laisalmi, M., Savolainen, J., Rautio, J. and Lehtonen, M., Diclofenac readily penetrates the cerebrospinal fluid in children. Br. J. Clin. Pharmacol. 2008. 65: 879-884.
51. Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E. et al., An essential role for ectodomain shedding in mammalian development. Science 1998. 282: 1281-1284.
52. Gomez-Gaviro, M., Dominguez-Luis, M., Canchado, J., Calafat, J., Janssen, H., Lara-Pezzi, E., Fourie, A. et al., Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding. J. Immunol. 2007. 178: 8053-8063.
53. Smalley, D. M. and Ley, K., L-selectin: mechanisms and physiological significance of ectodomain cleavage. J. Cell Mol. Med. 2005. 9: 255-266.
54. Schleiffenbaum, B., Spertini, O. and Tedder, T. F., Soluble L-selectin is present in human plasma at high levels and retains functional activity. J. Cell Biol. 1992. 119: 229-238.
55. Ferri, L. E., Pascual, J., Seely, A. J., Chaudhury, P. and Christou, N. V., Soluble L-selectin attenuates tumor necrosis factor-alpha-mediated leukocyte adherence and vascular permeability: a protective role for elevated soluble L-selectin in sepsis. Crit. Care Med. 2002. 30: 1842-1847.
56. Zhang, Z., Oliver, P., Lancaster, J. R., Jr., Schwarzenberger, P. O., Joshi, M. S., Cork, J. and Kolls, J. K., Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J. 2001. 15: 303-305.
57. Gorzalczany, Y., Sigal, N., Itan, M., Lotan, O. and Pick, E., Targeting of Rac1 to the phagocyte membrane is sufficient for the induction of NADPH oxidase assembly. J. Biol. Chem. 2000. 275: 40073-40081.
58. Hultqvist, M., Olsson, L. M., Gelderman, K. A. and Holmdahl, R., The protective role of ROS in autoimmune disease. Trends Immunol. 2009. 30: 201-208.
59. Hyun, Y. M., Lefort, C. T. and Kim, M., Leukocyte integrins and their ligand interactions. Immunol. Res. 2009. 45: 195-208.
60. Schlag, G., Redl, H. R., Till, G. O., Davies, J., Martin, U. and Dumont, L., Anti-L-selectin antibody treatment of hemorrhagic-traumatic shock in baboons. Crit. Care. Med. 1999. 27: 1900-1907.
61. Takada, M., Nadeau, K. C., Shaw, G. D., Marquette, K. A. and Tilney, N. L., The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J. Clin. Invest. 1997. 99: 2682-2690.
62. Mackay, C. R., Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat. Immunol. 2008. 9: 988-998.
63. Seekamp, A., van Griensven, M., Dhondt, E., Diefenbeck, M., Demeyer, I., Vundelinckx, G., Haas, N. et al., The effect of anti-L-selectin (aselizumab) in multiple traumatized patients-results of a phase II clinical trial. Crit. Care Med. 2004. 32: 2021-2028.
64. Mayr, F. B., Firbas, C., Leitner, J. M., Spiel, A. O., Reiter, R. A., Beyer, D., Meyer, M. et al., Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia. Shock 2008. 29: 475-482.
65. Alon, R., Kassner, P. D., Carr, M. W., Finger, E. B., Hemler, M. E. and Springer, T. A., The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 1995. 128: 1243-1253.
66. Amin, A. R., Vyas, P., Attur, M., Leszczynska-Piziak, J., Patel, I. R., Weissmann, G. and Abramson, S. B., The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA 1995. 92: 7926-7930.
67. Xu, X. M., Sansores-Garcia, L., Chen, X. M., Matijevic-Aleksic, N., Du, M. and Wu, K. K., Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc. Natl. Acad. Sci. USA 1999. 96: 5292-5297.
68. Gomez-Gaviro, M. V., Dominguez-Jimenez, C., Carretero, J. M., Sabando, P., Gonzalez-Alvaro, I., Sanchez-Madrid, F. and Diaz-Gonzalez, F., Down-regulation of L-selectin expression in neutrophils by nonsteroidal anti-inflammatory drugs: role of intracellular ATP concentration. Blood 2000. 96: 3592-3600.
69. Tegeder, I., Niederberger, E., Israr, E., Guhring, H., Brune, K., Euchenhofer, C., Grosch, S. et al., Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J. 2001. 15: 595-597.
70. Gonzalez-Alvaro, I., Munoz, C., Garcia-Vicuna, R., Sabando, P., Cabanas, C., Sanchez-Madrid, F. and Diaz-Gonzalez, F., Interference of nonsteroidal antiinflammatory drugs with very late activation antigen 4/vascular cells adhesion molecule 1-mediated lymphocyte-endothelial cell adhesion. Arthritis Rheum. 1998. 41: 1677-1688.
71. Yamamoto, Y., Yin, M. J., Lin, K. M. and Gaynor, R. B., Sulindac inhibits activation of the NF-kappaB pathway. J. Biol. Chem. 1999. 274: 27307-27314.
72. Shen, Y., Yang, T., Wang, J., Xu, Q., Li, R., Pan, W., Li, G. et al., Indomethacin enhances the cytotoxicity of recombinant human lymphotoxin alpha on tumor cells by suppressing NFkappaB signaling. Cancer Biol. Ther. 2007. 6: 1428-1433.
73. Gonzalez-Alvaro, I., Carmona, L., Diaz-Gonzalez, F., Gonzalez-Amaro, R., Mollinedo, F., Sanchez-Madrid, F., Laffon, A. et al., Aceclofenac, a new nonsteroidal antiinflammatory drug, decreases the expression and function of some adhesion molecules on human neutrophils. J. Rheumatol. 1996. 23: 723-729.